Abstract
Hepatic encephalopathy is considered a contraindication to hepatic artery embolization. We describe a patient with a well-differentiated neuroendocrine tumor metastatic to the liver with refractory hepatic encephalopathy and normal liver function tests. The encephalopathy was refractory to standard medical therapy with lactulose. The patient’s mental status returned to baseline after three hepatic artery embolization procedures. Arteriography and ultrasound imaging before and after embolization suggest that the encephalopathy was due to arterioportal shunting causing hepatofugal portal venous flow and portosystemic shunting. In patients with a primary or metastatic well-differentiated neuroendocrine tumor whose refractory hepatic encephalopathy is due to portosystemic shunting (rather than global hepatic dysfunction secondary to tumor burden), hepatic artery embolization can be performed safely and effectively.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albrecht J, Jones EA (1999) Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 170:138–146
Cordoba J, Minguez B (2008) Hepatic encephalopathy. Semin Liver Dis 28:70–80
Moriyasu F, Ban N, Nishida O et al (1986) Portal hemodynamics in patients with hepatocellular carcinoma. Radiology 161:707–711
Minguez B, Garcia-Pagan JC, Bosch J et al (2006) Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 43:707–714
Cooney TG, Bauer DC, Knauer CM (1980) Portal hypertension associated with hepatocellular carcinoma without cirrhosis. Am J Gastroenterol 74:436–438
Levy LJ, Swinburne LM, Boulton RP, Losowsky MS (1986) Primary hepatocellular carcinoma presenting as fulminant hepatic failure in a young woman. Postgrad Med J 62:1135–1137
Pal NR, Whittingham GE, Paley RG (1965) Hepatic coma due to liver metastases. Br Med J 1:168
Clay AS, Hainline BE (2007) Hyperammonemia in the ICU. Chest 132:1368–1378
Butterworth RF (2001) Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings. Metab Brain Dis 16:55–65
Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235
Ruers T, Bleichrodt RP (2002) Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38:1023–1033
Maluccio MA, Covey AM, Porat LB et al (2008) Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 19:862–869
Brown DB, Geschwind JF, Soulen MC, Millward SF, Sacks D (2006) Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 17:217–223
Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF (2002) Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 13:S211–S221
Alexopoulou A, Koskinas J, Deutsch M et al (2006) Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature. Tumori 92:354–357
Kapoor BS, Hunter DW, Greeno E, Pambuccian S, Sielaff T (2003) Hepatic encephalopathy secondary to transtumoral portal-hepatic venous shunting. Hepatogastroenterology 50:4–7
Sekido H, Nakano A, Takahashi T et al (1992) Hepatic encephalopathy secondary to a large-caliber porto-hepatic venous shunt. A case report. Hepatogastroenterology 39:316–318
Yamamoto T, Kuyama Y, Takeuchi K et al (2003) Hepatic encephalopathy due to portal venous thrombosis in a patient with pancreatic tumor. Pancreas 26:313–314
Major LF, Brown GL, Wilson WP (1973) Carcinoid and psychiatric symptoms. South Med J 66:787–790
Rosenthal MA (2004) Carcinoid associated encephalitis successfully treated with tryptophan. J Clin Neurosci 11:66–67
Patchell RA, Posner JB (1986) Neurologic complications of carcinoid. Neurology 36:745–749
Stojadinovic A, Allen PJ, Shriver CD (2002) Metastatic carcinoid tumour presenting as hepatic encephalopathy. HPB (Oxford) 4:47–50
Blendis L, Wong F (2001) The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 89:221–231
Iwakiri Y, Groszmann RJ (2006) The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 43:S121–S131
Grozinsky-Glasberg S, Shimon I, Korbonits M, Grossman AB (2008) Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms. Endocr Relat Cancer 15:701–720
Chatila R, Ferayorni L, Gupta T, Groszmann RJ (2000) Local arterial vasoconstriction induced by octreotide in patients with cirrhosis. Hepatology 31:572–576
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erinjeri, J.P., Deodhar, A., Thornton, R.H. et al. Resolution of Hepatic Encephalopathy Following Hepatic Artery Embolization in a Patient with Well-Differentiated Neuroendocrine Tumor Metastatic to the Liver. Cardiovasc Intervent Radiol 33, 610–614 (2010). https://doi.org/10.1007/s00270-009-9698-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-009-9698-0